Weng Meilin, Guo Miaomiao, Li Ting, Zhou Changming, Sun Caihong, Yue Ying, Liao Qingwu, Cai Sanjun, Lu Xihua, Zhou Di, Miao Changhong
Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Perioperative Stress and Protection, Zhongshan Hospital Fudan University, Shanghai, China.
Front Oncol. 2022 Aug 15;12:940428. doi: 10.3389/fonc.2022.940428. eCollection 2022.
Perioperative anemia and transfusion are intertwined with each other, and both have adverse impacts on the survival of colorectal cancer (CRC) patients. But the treatment of anemia still relies on transfusion in several countries, which leads us to question the effects of anemia tolerance and transfusion on the long-term outcomes of CRC patients. We investigated the combined effect of preoperative anemia and postoperative anemia and of preoperative anemia and blood transfusion, which imposes a greater risk to survival, to compare the effects of anemia tolerance and transfusion on overall survival (OS) and disease-free survival (DFS) in patients undergoing CRC surgery.
A retrospective propensity-score-matched analysis included patients with CRC undergoing elective surgery between January 1, 2008, and December 31, 2014. After propensity-score matching, Kaplan-Meier survival analysis and univariable and multivariable Cox proportional hazards models were used to study the prognostic factors for survivals. In univariate and multivariate Cox regression analysis, two novel models were built.
Of the 8,121 patients with CRC, 1,975 (24.3%) and 6,146 (75.7%) patients presented with and without preoperative anemia, respectively. After matching, 1,690 patients remained in each group. In the preoperative anemia and postoperative anemia model, preoperative anemia and postoperative anemia was independent risk factor for OS (HR, 1.202; 95% CI, 1.043-1.385; P=0.011) and DFS (HR, 1.210; 95% CI, 1.050-1.395; P=0.008). In the preoperative anemia and transfusion model, preoperative anemia and transfused was the most dangerous independent prognostic factor for OS (HR, 1.791; 95% CI, 1.339-2.397; P<0.001) and DFS (HR, 1.857; 95% CI, 1.389-2.483; P<0.001). In patients with preoperative anemia, the OS and DFS of patients with transfusion were worse than those of patients without transfusion (P=0.026 in OS; P=0.037 in DFS).
Preoperative anemia and blood transfusion imposed a greater risk to OS and DFS in patients undergoing CRC surgery, indicating that the harm associated with blood transfusion was greater than that associated with postoperative anemia. These findings should encourage clinicians to be vigilant for the timely prevention and treatment of anemia, by appropriately promoting toleration of anemia and restricting the use of blood transfusion in patients with CRC.
围手术期贫血与输血相互关联,二者均对结直肠癌(CRC)患者的生存产生不利影响。但在一些国家,贫血治疗仍依赖输血,这使我们质疑贫血耐受性和输血对CRC患者长期预后的影响。我们研究了术前贫血与术后贫血以及术前贫血与输血的联合作用,其对生存构成更大风险,以比较贫血耐受性和输血对接受CRC手术患者的总生存期(OS)和无病生存期(DFS)的影响。
一项回顾性倾向评分匹配分析纳入了2008年1月1日至2014年12月31日期间接受择期手术的CRC患者。在倾向评分匹配后,采用Kaplan-Meier生存分析以及单变量和多变量Cox比例风险模型研究生存的预后因素。在单变量和多变量Cox回归分析中,构建了两个新模型。
在8121例CRC患者中,分别有1975例(24.3%)和6146例(75.7%)患者存在和不存在术前贫血。匹配后,每组各有1690例患者。在术前贫血与术后贫血模型中,术前贫血和术后贫血是OS(风险比[HR],1.202;95%置信区间[CI],1.043 - 1.385;P = 0.011)和DFS(HR,1.210;95% CI,1.050 - 1.395;P = 0.008)的独立危险因素。在术前贫血与输血模型中,术前贫血和输血是OS(HR,1.791;95% CI,1.339 - 2.397;P < 0.001)和DFS(HR,1.857;95% CI,1.389 - 2.483;P < 0.001)最危险的独立预后因素。在术前贫血患者中,输血患者的OS和DFS比未输血患者更差(OS中P = 0.026;DFS中P = 0.037)。
术前贫血和输血对接受CRC手术患者的OS和DFS构成更大风险,表明与输血相关的危害大于与术后贫血相关的危害。这些发现应促使临床医生警惕及时预防和治疗贫血,通过适当提高对贫血的耐受性并限制CRC患者输血的使用。